Orion
Chasing rivals, Bayer files Nubeqa for new prostate cancer use
Phil Taylor
Bayer, Nubeqa, Oncology, Orion, Prostate cancer, regulatory
0 Comment
Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Virtual reality therapy: The future of chronic pain management?
Catherine Longworth
Chronic pain, Healthware, Orion, virtual reality, VR
0 Comment
Trial finds Orion digital therapeutic helps chronic pain sufferers
Phil Taylor
CBT, chronic lower back pain, Chronic pain, digital, digital health, Orion
0 Comment
Bayer aims at J&J and Pfizer with new prostate cancer drug
Richard Staines
Astellas, Bayer, Johnson & Johnson, Orion, Pfizer, Prostate cancer
0 Comment
Bayer/Orion showcase results from prostate cancer challenger
Richard Staines
Astellas, Bayer, cancer, Johnson & Johnson, Orion, Prostate cancer
0 Comment
Digital/ Digital and Social Media/ News/ News/ US
‘Bionic eye’ receives FDA fast-track review designation
Marco Ricci
blindness, digital health, fda, medical devices, Orion, Second Sight
0 Comment
Review of Second Sight’s Orion will now be streamlined.